Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats

Biochemical and Biophysical Research Communications

Volumn 315, Issue 2, 2004, Pages 509-516

  Quan, Shou ^a   Kaminski, Pawel M ^a   Yang, Liming ^a   Morita, Toshisuke ^b   Inaba, Muneo ^c   Ikehara, Susumu ^c   Goodman, Alvin I ^a   Wolin, Michael S ^a   Abraham, Nader G ^a,d  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b TOHO UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Circulating endothelial cells; Heme oxygenase; HO 1 gene regulation

Indexed keywords

BILIRUBIN; HEME OXYGENASE 1; OXYGEN; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINASE INHIBITION; RAT; STREPTOZOCIN DIABETES; UPREGULATION;

EID: 0842288986     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.086     Document Type: Article

References (68)

1. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
2. Karpen C.W., Cataland S., O'Dorisio T.M., Panganamala R.V. Production of 12-hydroxyeicosatetraenoic acid and vitamin E status in platelets from type I human diabetic subjects. Diabetes. 34:1985;526-531.
3. Davi G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., Pennese E., Vitacolonna E., Bucciarelli T., Costantini F., Capani F., Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 99:1999;224-229.
4. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.E., Kern T.S., Ballas L.M., Heath W.F., Stramm L.E., Feener E.P., King G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 272:1996;728-731.
5. Bleich D., Chen S., Zipser B., Sun D., Funk C.D., Nadler J.L. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J. Clin. Invest. 103:1999;1431-1436.
6. Abraham N.G., Kushida T., McClung J., Quan S., Lafaro R., Darzynkiewicz Z., Wolin M.S. Heme oxygenase-1 attenuates glucose mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res. 93:2003;131-139.
7. Zou M.H., Shi C., Cohen R.A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H2 receptor-mediated apoptosis and adhesion molecular expression in cultured human aortic endothelial cells. Diabetes. 51:2002;198-203.
8. Lorenzi M., Nordberg J.A., Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes. 36:1987;1261-1267.
9. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Grillari J., Gessl A., Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes. 44:1995;1323-1327.
10. Lorenzi M., Cagliero E., Toledo S. Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes. 34:1985;621-627.
11. Curcio F., Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell. Dev. Biol. 28A:1992;787-790.
12. Ceriello A., dello R.P., Amstad P., Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes. 45:1996;471-477.
13. Abraham N.G., Drummond G.S., Lutton J.D., Kappas A. The biological significance and physiological role of heme oxygenase. Cell. Physiol. Biochem. 6:1996;129-168.
14. Haugen E.N., Croatt A.J., Nath K.A. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int. 58:2000;144-152.
15. Nath K.A., Vercellotti G.M., Grande J.P., Miyoshi H., Paya C.V., Manivel J.C., Haggard J.J., Croatt A.J., Payne W.D., Alam J. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int. 59:2001;106-117.
16. Ishizaka N., De Leon H., Laursen J.B., Fukui T., Wilcox J.N., De Keulenaer G., Griedling K.K., Alexander R.W. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation. 96:1994;1923-1929.
17. 2+, and phospholipase A2 in endothelial cells. Am. J. Physiol. 276:1999;H1493-H1501.
18. Rizzardini M., Terao M., Falciani F., Cantoni L. Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem. J. 290(Pt 2):1993;343-347.
19. Yet S.F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., Ith B., Melo L.G., Zhang L., Ingwall J.S., Dzau V.J., Lee M.E., Perrella M.A. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ. Res. 89:2001;168-173.
20. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S., Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66:2000;187-195.
21. Neil T.K., Stoltz R.A., Jiang S., Dunn M.W., Levere R.D., Kappas A., Abraham N.G. Modulation of corneal heme oxygenase expression by oxidative stress agents. J. Ocul. Pharmacol. Ther. 11:1995;455-468.
22. Nath K.A., Haggard J.J., Croatt A.J., Grande J.P., Poss K.D., Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156:2000;1527-1535.
23. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science (Washington DC). 235:1987;1043-1047.
24. Stocker R., McDonagh A.F., Glazer A.N., Ames B.N. Antioxidant activities of bile pigments: biliverdin and bilirubin3. Methods Enzymol. 186:1990;301-309.
25. Baranano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA. 99:2002;16093-16098.
26. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA. 94:1997;10919-10924.
27. Ferris C.D., Jaffrey S.R., Sawa A., Takahashi M., Brady S.D., Barrow R.K., Tysoe S.A., Wolosker H., Baranano D.E., Dore S., Poss K.D., Snyder S.H. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1:1999;152-157.
28. Otterbein L.E., Kolls J.K., Mantell L.L., Cook J.L., Alam J., Choi A.M. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103:1999;1047-1054.
29. Wagener F.A.D.T.G., da Silva J.-L., Farley T., de Witte T., Kappas A., Abraham N.G. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J. Pharmacol. Exp. Ther. 291:1999;416-423.
30. Hayashi S., Takamiya R., Yamaguchi T., Matsumoto K., Tojo S.J., Tamatani T., Kitajima M., Makino N., Ishimura Y., Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 85:1999;663-671.
31. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192:2000;1015-1026.
32. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao L.H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:2000;422-428.
33. Solovey A., Lin Y., Browne P., Choong S., Wayner E., Hebbel R.P. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337:1997;1584-1590.
34. Mutin M., Canavy I., Blann A., Bory M., Sampol J., Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood. 93:1999;2951-2958.
35. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89:2001;E1-E7.
36. Woywodt A., Streiber F., de Groot K., Regelsberger H., Haller H., Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet. 361:2003;206-210.
37. Challah M., Nadaud S., Philippe M., Battle T., Soubrier F., Corman B., Michel J.B. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am. J. Physiol. 273:1997;H1941-H1948.
38. Quan S., Yang L., Abraham N.G., Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc. Natl. Acad. Sci. USA. 98:2001;12203-12208.
39. Yang L., Quan S., Abraham N.G. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am. J. Physiol. 277:1999;L127-L133.
40. Quan S., Yang L., Shenouda S., Jiang H., Balazy M., Schwartzman M.L., Shibahara I., Shinohara K., Abraham N.G. Functional expression of human heme oxygenase-1 (HO-1) driven by HO-1 promoter in vitro and in vivo. J. Cell. Biochem. 85:2002;1-12.
41. Oeckler R.A., Kaminski P.M., Wolin M.S. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ. Res. 92:2003;23-31.
42. Abraham N.G., Lin J.H., Schwartzman M.L., Levere R.D., Shibahara S. The physiological significance of heme oxygenase. Int. J. Biochem. 20:1988;543-558.
43. Bitar M., Weiner M. Heme and hemoproteins in streptozotocin-diabetic female rats. Biochem. Pharmacol. 32:1983;1921-1928.
44. Bitar M., Weiner M. Diabetes-induced metabolic alterations in heme synthesis and degradation and various heme-containing enzymes in female rats. Diabetes. 33:1984;37-44.
45. Mohazzab H., Kaminski P.M., Fayngersh R.P., Wolin M.S. Oxygen-elicited responses in calf coronary arteries: role of H2O2 production via NADH-derived superoxide. Am. J. Physiol. 1996;H1044-H1053.
46. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1996;1916-1923.
47. Abraham N.G., Lavrovsky Y., Schwartzman M.L., Stoltz R.A., Levere R.D., Gerritsen M.E., Shibahara S., Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc. Natl. Acad. Sci. USA. 92:1995;6798-6802.
48. Chang S.H., Barbosa-Tessmann I., Chen C., Kilberg M.S., Agarwal A. Glucose deprivation induces heme oxygenase-1 gene expression by a pathway independent of the unfolded protein response. J. Biol. Chem. 277:2002;1933-1940.
49. Nath K.A., Croatt A.J., Haggard J.J., Grande J.P. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int. 57:2000;2423-2433.
50. Takamiya R., Murakami M., Kajimura M., Goda N., Makino N., Takamiya Y., Yamaguchi T., Ishimura Y., Hozumi N., Suematsu M. Stabilization of mast cells by heme oxygenase-1: an anti-inflammatory role. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H861-H870.
51. Nath K.A., Haggard J.J., Croatt A.J., Grande J.P., Poss K.D., Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156:2000;1527-1535.
52. Biberstine-Kinkade K.J., DeLeo F.R., Epstein R.I., LeRoy B.A., Nauseef W.M., Dinauer M.C. Heme-ligating histidines in flavocytochrome b(558): identification of specific histidines in gp91(phox). J. Biol. Chem. 276:2001;31105-31112.
53. Finegold A.A., Shatwell K.P., Segal A.W., Klausner R.D., Dancis A. Intramembrane bis-heme motif for transmembrane electron transport conserved in a yeast iron reductase and the human NADPH oxidase. J. Biol. Chem. 271:1996;31021-31024.
54. Maturana A., Arnaudeau S., Ryser S., Banfi B., Hossle J.P., Schlegel W., Krause K.H., Demaurex N. Heme histidine ligands within gp91(phox) modulate proton conduction by the phagocyte NADPH oxidase. J. Biol. Chem. 276:2001;30277-30284.
55. Verrotti A., Trotta D., Salladini C., Laura M., Chiarelli F. Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control. Expert Opin. Pharmacother. 4:2003;525-532.
56. Mazza F., Goodman A.I., Lombardo G., Vanella A., Abraham N.G. Heme oxygenase I gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells. Exp. Biol. Med. 228:2003;576-583.
57. Hayashi K., Haneda M., Koya D., Maeda S., Isshiki K., Kikkawa R. Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res. Clin. Pract. 52:2001;85-96.
58. Wang R., Wang Z., Wu L., Hanna S.T., Peterson-Wakeman R. Reduced vasorelaxant effect of carbon monoxide in diabetes and the underlying mechanisms. Diabetes. 50:2001;166-174.
59. da-Silva J.L., Stoltz R.A., Dunn M.W., Abraham N.G., Shibahara S. Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. Curr. Eye Res. 16:1997;380-386.
60. Bruce C.R., Carey A.L., Hawley J.A., Febbraio M.A. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes. 52:2003;2338-2345.
61. Minamino T., Christou H., Hsieh C.M., Liu Y., Dhawan V., Abraham N.G., Perrella M.A., Mitsialis S.A., Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. USA. 98:2001;8798-8803.
62. The Diabetic Control, N. Eng. J. Med. 329 (1993) 977-986.
63. Stehouwer C.D., Schaper N.C. The pathogenesis of vascular complications of diabetes mellitus: one voice or many? Eur. J. Clin. Invest. 26:1996;535-543.
64. Stehouwer C.D., Donker A.J. Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus. Neth. J. Med. 42:1993;175-186.
65. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103:1999;129-135.
66. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase-1 deficient cells. Proc. Natl. Acad. Sci. USA. 94:1997;10925-10930.
67. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1994;1141-1148.
68. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:2000;494-501.